Thrivent Financial For Lutherans Sutro Biopharma, Inc. Transaction History
Thrivent Financial For Lutherans
- $51.6 Billion
- Q4 2024
A detailed history of Thrivent Financial For Lutherans transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 97,096 shares of STRO stock, worth $173,801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,096Holding current value
$173,801% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
138Shares Held
61.6MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$12.9 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$7.53 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3MShares$5.37 Million0.03% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$5.07 Million1.53% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $93.4M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...